Cedar Wealth Management, LLC Acelrx Pharmaceuticals Inc Transaction History

Cedar Wealth Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$1.25 - $2.77 $12,500 - $27,700	-10,000 Reduced 66.67%	5,000 $9,000
Q4 2019 Jan 29, 2020	SELL	$1.66 - $2.4 $52,115 - $75,348	-31,395 Reduced 67.67%	15,000 $32,000
Q4 2018 Jan 23, 2019	BUY	$2.13 - $4.8 $26,625 - $60,000	12,500 Added 36.88%	46,395 $107,000
Q3 2018 Nov 06, 2018	BUY	$2.6 - $4.6 $56,927 - $100,716	21,895 Added 182.46%	33,895 $130,000
Q2 2018 Aug 07, 2018	BUY	$2.13 - $4.2 $4,260 - $8,400	2,000 Added 20.0%	12,000 $41,000
Q4 2017 Feb 02, 2018	BUY	$1.75 - $5.5 $17,500 - $55,000	10,000	10,000 $20,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Cedar Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cedar Wealth Management, LLC with notifications on news.